June 2026– date –
-
Syntax Bio and Applied StemCell Partner to Accelerate Allogeneic Cell Therapies with GMP-Compliant Hypoimmune iPSCs and Cellgorithm Platform
CRISPR Medicine News USA Overview Syntax Bio and Applied StemCell have forged a strategic collaboration to propel next-generation regenerative medicine by advancing stem cell innovation. Applied StemCell will supply GMP-compatible hypoim... -
arXiv Paper: Raman Data Fusion with Latent ODE Enhances Cell Culture Process Forecasting Accuracy
arXiv (Preprint) Global Overview New research published on arXiv proposes an innovative approach to improve cell culture process forecasting accuracy by fusing Raman spectroscopy data with a 'Multipath Adaptive Gated Bottleneck Latent OD... -
Data Integrity in Bioprocessing: ALCOA+ Compliance Critical for Ensuring Reliability of GMP Records
Lab Manager Global Overview In bioprocessing labs, data integrity and adherence to ALCOA+ principles are critical for meeting regulatory expectations and ensuring product safety and efficacy. All GMP records, including those from bioreac... -
In-Line Sensors Play Crucial Role in Single-Use Biomanufacturing, Driving PAT Adoption and Enhancing Process Control
Technology Networks Global Overview In-line sensors are proving indispensable in single-use biomanufacturing for improving process efficiency and reliability. Directly integrated into single-use bioreactor bags, these sensors enable cont... -
Bioprocessing Technologies Reshape Food Production, Environmental Applications, and Sustainable Manufacturing Beyond Pharma
Technology Networks Global Overview Bioprocessing technologies are redefining various industries beyond pharmaceuticals, including food production, environmental applications, and sustainable manufacturing. Key technologies like fermenta... -
REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stemchymal® Stem Cell Therapy for Spinocerebellar Ataxia (SCA3 and SCA6)
BioSpace Japan Overview REPROCELL Inc. has submitted an application for manufacturing and marketing approval in Japan for its regenerative medicine product, Stemchymal®, aimed at inhibiting the progression of motor ataxia in patients wit... -
AI and Machine Learning Optimize Protein Design for Cost Efficiency in Large-Scale Production, Achieving 20-30% Energy Reduction
PatSnap Eureka Global Overview Optimizing protein design for maximizing cost efficiency in large-scale production is significantly advanced by computational algorithms, machine learning, molecular dynamics simulations, and artificial int... -
Samsung Biologics Revolutionizes Bioprocess Manufacturing Intelligence by Integrating Digital Twin and AI for Proactive Decision-Making
Samsung Biologics South Korea Overview Samsung Biologics is revolutionizing manufacturing intelligence by advancing a digital bioprocess framework integrating multivariate data analysis (MVDA), predictive modeling, and explainable AI. Th... -
Lonza’s OptiALTO™ Platform Leverages Raman Spectroscopy as PAT to Significantly Boost High-Cell-Density Culture Productivity
Lonza Switzerland Overview Lonza's OptiALTO™ platform is achieving significant increases in productivity for high-cell-density cultures by integrating Raman spectroscopy as a Process Analytical Technology (PAT). This innovative approach ... -
UniXell Biotechnology Secures US FDA IND Clearance for Off-the-Shelf Parkinson’s Cell Therapy UX-DA003, Accelerating Dual China-US Clinical Development
BioPharma APAC USA Overview UniXell Biotechnology announced that its allogeneic iPSC-derived therapy UX-DA003 for Parkinson's disease has received Investigational New Drug (IND) approval from the US FDA. This approval enables the company...
